Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis

Clinical Endocrinology

Volumn 75, Issue 6, 2011, Pages 857-863

  Han, Der Sheng ^a,b   Chen, Yung Ming ^a   Lin, Sen Yung ^a   Chang, Hao Hsiang ^a   Huang, Tao Min ^a   Chi, Yu Chiao ^b   Yang, Wei Shiung ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSTATIN; SOMATOMEDIN C;

ADULT; AGE; AGED; ARTICLE; ARTIFICIAL KIDNEY; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; GRIP STRENGTH; HEMODIALYSIS; HUMAN; MAINTENANCE HAEMODIALYSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; PRIORITY JOURNAL; RISK;

ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HAND STRENGTH; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOSTATIN; ORGAN SIZE; RENAL DIALYSIS;

EID: 80855144840     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04120.x     Document Type: Article

References (39)

1. McPherron, A.C., Lawler, A.M., &, Lee, S.J., (1997) Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature, 387, 83-90. (Pubitemid 27202654)
2. Zimmers, T.A., Davies, M.V., Koniaris, L.G., et al. (2002) Induction of cachexia in mice by systemically administered myostatin. Science, 296, 1486-1488. (Pubitemid 34553097)
3. Bogdamovich, S., Krag, T.O.B., Barton, E.R., et al. (2002) Functional improvement of dystrophic muscle by myostatin blockage. Nature, 420, 418-421. (Pubitemid 35415652)
4. Schuelke, M., Wagner, K.R., Stolz, L.E., et al. (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. New England Journal of Medicine, 350, 2682-2688. (Pubitemid 38788003)
5. Seibert, M.J., Xue, Q.-L., Fried, L.P., et al. (2001) Polymorphic variation in the human myostatin (GDF-8) gene and association with strength measures in the Women's Health and Aging Study II Cohort. Journal of the American Geriatrics Society, 49, 1093-1096. (Pubitemid 32801148)
6. Sharma, M., Langley, B., Bass, J., et al. (2001) Myostatin in muscle growth and repair. Exercise and Sport Sciences Reviews, 29, 155-158. (Pubitemid 33596396)
7. Shyu, K.G., Ko, W.H., Yang, W.S., et al. (2005) Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes. Cardiovascular Research, 68, 405-414.
8. Gaussin, V., &, Depre, C., (2005) Myostatin, the cardiac chalone of insulin-like growth factor-1. Cardiovascular Research, 68, 347-349. (Pubitemid 41566552)
9. Lee, S.J., &, McPherron, A.C., (2001) Regulation of myostatin activity and muscle growth. Proceedings of the National Academy of Sciences, 98, 9306-9311. (Pubitemid 32743912)
10. Rios, R., Fernandez-Nocelos, S., Carneiro, I., et al. (2003) Differential response to exogenous and endogenous myostatin in myoblasts suggests that myostatin acts as an autocrine factor in vivo. Endocrinology, 145, 2795-2803. (Pubitemid 38686229)
11. Du, J., Hu, Z., &, Mitch, W.E., (2005) Molecular mechanisms activating muscle protein degradation in chronic kidney disease and other catabolic conditions. European Journal of Clinical Investigation, 35, 157-163. (Pubitemid 40343880)
12. Mak, R.H., &, Rotwein, P., (2006) Myostatin and insulin-like growth factors in uremic sarcopenia: the yin and yang in muscle mass regulation. Kidney International, 70, 410-412. (Pubitemid 44141565)
13. Heimbürger, O., Qureshi, A.R., Blaner, W.S., et al. (2000) Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. American Journal of Kidney Diseases, 36, 1213-1225.
14. Rockel, A., Hertel, J., Fiegel, P., et al. (1986) Permeability and secondary membrane formation of a high flux polysulfone hemofilter. Kidney International, 30, 429-432. (Pubitemid 16029515)
15. Gonzalez-Cadavid, N.F., Taylor, W.E., Yarasheski, K., et al. (1998) Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proceedings of the National Academy of Sciences, 95, 14938-14943. (Pubitemid 29003735)
16. Okamoto, T., Masuhara, M., &, Ikuta, K., (2009) Home-based resistance training improves arterial stiffness in healthy premenopausal women. European Journal of Applied Physiology, 107, 113-117.
17. Kotanko, P., Levin, N.W., &, Zhu, F., (2008) Current state of bioimpedance technologies in dialysis. Nephrology Dialysis and Transplantation, 23, 808-812. (Pubitemid 351767595)
18. Mathiowetz, V., Kashman, N., Volland, G., et al. (1985) Grip and pinch strength: normative data for adults. Archives of Physical Medicine and Rehabilitation, 66, 69-72.
19. Cheung, A.K., Levin, N.W., Greene, T., et al. (2003) Effects of high-flux haemodialysis on clinical outcomes: results of the HEMO Study. Journal of the American Society of Nephrology, 14, 3251-3263. (Pubitemid 37509301)
20. DeSilva, B., Smith, W., Weiner, R., et al. (2003) Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharmaceutical Research, 20, 1885-1900. (Pubitemid 37449466)
21. Xing, F., Tan, X., Zhang, P.J., et al. (2007) Characterization of amphioxus GDF8/11 gene, an archetype of vertebrate MSTN and GDF11. Development Genes and Evolution, 217, 549-554. (Pubitemid 47322122)
22. Jones, G., Wortberg, M., Kreissig, S.B., et al. (1994) Extension of the four-parameter logistic model for ELISA to multianalyte analysis. Journal of Immunological Methods, 177, 1-7.
23. Bergström, J., &, Wehle, B., (1987) No change in corrected β2-microglobulin concentration after cuprophane haemodialysis. The Lancet, 329, 628-629. (Pubitemid 17024248)
24. Kloppenburg, W.D., Stegeman, C.A., Hooyschuur, M., et al. (1999) Assessing dialysis adequacy and dietary intake in the individual haemodialysis patient. Kidney International, 55, 1961-1969. (Pubitemid 29197985)
25. Ma, K., Mallids, C., Bhasin, S., et al. (2003) Glucocorticoid-induced skeletal muscle atrophy is associated with upregulation of myostatin gene expression. American Journal of Physiology Endocrinology Metabolism, 285, E363-E371. (Pubitemid 36899710)
26. Hosoyama, T., Tachi, C., Yamanouchi, K., et al. (2009) Long term adrenal insufficiency induces skeletal muscle atrophy and increases the serum levels of active form myostatin in rat serum. Zoological Science, 22, 229-236. (Pubitemid 40599832)
27. Lakshman, K.M., Bhasin, S., Corcoran, C., et al. (2009) Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration. Molecular and Cellular Endocrinology, 302, 26-32.
28. Oreopoulos, A., Ezekowitz, J.A., McAlister, F.A., et al. (2010) Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clinic Proceedings, 85, 609-617.
29. Shephard, R.J., Montelpare, W., Plyley, M., et al. (1991) Handgrip dynamometry, Cybex measurements and lean mass as markers of the ageing of muscle function. British Journal of Sports Medicine, 25, 204-208.
30. Maughan, R.J., Watson, J.S., &, Weir, J., (1983) Strength and cross-sectional area of human skeletal muscle. The Journal of Physiology, 338, 37-49. (Pubitemid 13099474)
31. Maughan, R.J., &, Nimmo, M.A., (1984) The influence of variations in muscle fibre composition on muscle strength and cross-sectional area in untrained males. The Journal of Physiology, 351, 299-311. (Pubitemid 14062851)
32. Kopple, J.D., Wang, H., Casaburi, R., et al. (2007) Exercise in maintenance haemodialysis patients induces transcriptional changes in genes favoring anabolic muscle. Journal of the American Society of Nephrology, 18, 2975-2986. (Pubitemid 350064083)
33. Sun, D.F., Chen, Y., &, Rabkin, R., (2006) Work-induced changes in skeletal muscle IGF-1 and myostatin gene expression in uremia. Kidney International, 70, 453-459. (Pubitemid 44141571)
34. Kaysen, G.A., (2004) Inflammation: cause of vascular disease and malnutrition in dialysis patients. Seminars in Nephrology, 24, 431-436. (Pubitemid 39361048)
35. Guernec, A., Chevalier, B., &, Duclos, M.J., (2004) Nutrient supply enhances both IGF-I and MSTN mRNA levels in chicken skeletal muscle. Domestic Animal Endocrinology, 26, 143-154. (Pubitemid 38192788)
36. Grimberg, A., &, Cohen, P., (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. Journal of Cellular Physiology, 183, 1-9. (Pubitemid 30130219)
37. Baxter, R.C., (1994) Insulin-like growth factor binding proteins in the human circulation: a review. Hormone Research, 42, 140-144. (Pubitemid 24336141)
38. Qureshi, A.R., Alvestrand, A., Divino-Filho, J.C., et al. (2002) Inflammation, malnutrition, and cardiac disease as predictors of mortality in haemodialysis patients. Journal of the American Society of Nephrology, 13, S28-S36.
39. Clark, W.R., Leypoldt, J.K., Henderson, L.W., et al. (1999) Quantifying the effect of changes in the haemodialysis prescription on effective solute removal with a mathematical model. Journal of the American Society of Nephrology, 10, 601-609. (Pubitemid 29117642)